Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : COVID-19 Jabs Supplied to Canada, Mexico From US Before Inspection of Plant Operations

07/29/2021 | 10:51am EDT


ę MT Newswires 2021
All news about ASTRAZENECA PLC
02:21aASTRAZENECA : Merck & Co.'s Prostate Cancer Drug Extends Lives in Late-Stage Study
MT
12:31aAstraZeneca's Prostate-Cancer Propel Phase 3 Trial Met Primary Point
DJ
09/23ASTRAZENECA : Australia hits vaccine milestone as Melbourne cases hover near record levels
RE
09/23ASTRAZENECA : Vaccination Against Covid-19 Resumes Sept 24
AQ
09/23VC DAILY : Biotechs Seek New Skill Set From -2-
DJ
09/23Redhill Biopharma, AstraZeneca, Nektar Therapeutics Settle Movantik Patent Litigation w..
MT
09/23WALL STREET STOCK EXCHANGE : As smooth as silk
09/23ASTRAZENECA : A Sense of Comfort, Providing Housing to Patients and their Families During ..
AQ
09/23ASTRAZENECA : Science Committee appointment (Form 6-K)
PU
09/23ASTRAZENECA : establishes new Sustainability Committee of the Board (Form 6-K)
PU
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 401 M - -
Net income 2021 5 006 M - -
Net Debt 2021 24 250 M - -
P/E ratio 2021 33,3x
Yield 2021 2,37%
Capitalization 184 B 184 B -
EV / Sales 2021 5,89x
EV / Sales 2022 4,78x
Nbr of Employees 76 100
Free-Float 96,3%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 118,94 $
Average target price 136,23 $
Spread / Average Target 14,5%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC18.35%184 418
JOHNSON & JOHNSON4.75%431 543
ROCHE HOLDING AG10.05%322 644
PFIZER, INC.19.40%246 414
NOVO NORDISK A/S50.62%232 291
ELI LILLY AND COMPANY37.51%206 972